Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ALEC - Alector Inc

IEX Last Trade
5.29
0.070   1.323%

Share volume: 380,065
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%
$5.22
0.07
1.34%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
25%
Profitability 25%
Dept financing 19%
Liquidity 67%
Performance 16%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-0.56%
1 Month
-15.65%
3 Months
7.32%
6 Months
-24.46%
1 Year
-6.55%
2 Year
-50.19%
Key data
Stock price
$5.29
P/E Ratio 
-3.20
DAY RANGE
N/A - N/A
EPS 
-$1.79
52 WEEK RANGE
$3.66 - $8.90
52 WEEK CHANGE
-$0.05
MARKET CAP 
513.855 M
YIELD 
N/A
SHARES OUTSTANDING 
97.321 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/05/2024
BETA 
2.02
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$379,455
AVERAGE 30 VOLUME 
$401,374
Company detail
CEO: Arnon Rosenthal
Region: US
Website: https://alector.com
Employees: 294
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

we are a biotech company based in san francisco dedicated to the discovery and development of novel therapies harnessing the power of immune system to treat neurodegenerative diseases such as alzheimer's disease.

Recent news